Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.7 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |